Alpine Global Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Alpine Global Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-162,912	Closed	-$144K	–	556
2022 Q4	$144K	Buy	+162,912	New	+$216K	0.05%	116
2022 Q1	–	Sell	-25,893	Closed	-$120K	–	816
2021 Q4	$120K	Buy	+25,893	New	+$161K	0.02%	622
2020 Q4	–	Sell	-30,200	Closed	-$337K	–	329
2020 Q3	$337K	Buy	+30,200	New	+$276K	0.07%	127
2020 Q1	–	Sell	-18,631	Closed	-$63K	–	491
2019 Q4	$63K	Buy	+18,631	New	+$44.4K	0.01%	383
2019 Q1	–	Sell	-148,195	Closed	-$356K	–	227
2018 Q4	$356K	Buy	+148,195	New	+$484K	0.09%	109
2018 Q2	–	Sell	-19,018	Closed	-$98K	–	127
2018 Q1	$98K	Sell	19,018 -18,864	-50%	-$134K	0.02%	96
2017 Q4	$144K	Buy	+37,882	New	+$98.7K	0.03%	142

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Alpine Global Management's SRNE Position: Q1 2023 in Review

Alpine Global Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 162,912 shares — an estimated $144K sold.

Alpine Global Management first reported a position in SRNE in Q4 2017 and held it in 7 quarters. The position peaked at $356K in Q4 2018. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Alpine Global Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Alpine Global Management sold 162,912 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $144K.
Alpine Global Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2017 and held it in 7 quarters.
Alpine Global Management's Sorrento Therapeutics, Inc. position peaked at $356K in Q4 2018.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.